FDA Application
Federal Register
Tuesday October 27, 2009
Planning to Submit Comments?
Documents and comments received by the Division of Dockets Management may be posted
on the Internet. Please do not include personal
identifying information, i.e. date of birth, social security number, medical
information, etc., in your correspondence.
Submit Electronic Comments
Documents are on display for public inspection at the Division of Dockets Management, 5630 Fishers Lane (Room 1061), HFA-305, Rockville, MD, 20852; 301-827-6860; TTY/TDD Users 1-800-735-2258.
FDA Federal Register Documents
NOTICES
Docket No. FDA-2009-N-0339, OC 2009299. Prescription Drug User Fee Rates for Fiscal Year 2010; Correction. Page 55244 [FR Doc. E9–25804] [OFR PUB]
Docket No. FDA-2004-N-0063, CDER 200886. Saccharomyces boulardii Eligibility for Consideration to Be Added to the Over-the-Counter Drug Monograph for Antidiarrheal Drug Products; Request for Safety and Effectiveness Data; Withdrawal. Pages 55245-55246 [FR Doc. E9–25803] [OFR PUB]
MEETINGS
Docket No. FDA-2009-N-0664, OC 2009297. Endocrinologic and Metabolic Drugs Advisory Committee. Pages 55243-55244 [FR Doc. E9–25805] [OFR PUB] Meeting on December 15, 2009
Docket No. FDA-2009-N-0664, OC 2009295. Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee. Page 55243 [FR Doc. E9–25806] [OFR PUB] Meeting on December 15, 2009
Docket No. FDA-2009-N-0664, CBER 200919. Emerging Arboviruses: Risk Assessment for Blood,Cell,Tissue, and Organ Safety; Public Workshop. Pages 55244-55245 [FR Doc. E9–25802] [OFR PUB] Workshop on December 14, 2009 and December 15, 2009
Table of Contents for Entire Federal Register
Tuesday, October 27, 2009
[Not Available]